Connell Patrick S, Price Jack F, Rusin Craig G, Howard Taylor S, Spinner Joseph A, Valdes Santiago O, Pham Tam Dan N, Miyake Christina Y, Kim Jeffrey J
Section of Pediatric Cardiology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, 6651 Main St., MS BCM320, Houston, TX, 77030, USA.
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, USA.
Pediatr Cardiol. 2024 Dec;45(8):1767-1775. doi: 10.1007/s00246-023-03279-7. Epub 2023 Sep 12.
Heart rate variability (HRV) is a noninvasive indicator of the health of neurocardiac interactions of the autonomic nervous system. In adults, decreased HRV correlates with increased cardiovascular mortality. However, the relationship between HRV and outcomes in children with acute decompensated heart failure (ADHF) has not been described. Patients < 21 years old hospitalized with ADHF from 2013 to 2019 were included (N = 79). Primary outcome was defined as death, heart transplant, or mechanical circulatory support (MCS). The median standard deviation of the R-to-R interval in 5-min intervals (SDNN) was calculated from telemetry data obtained across the first 24 h of admission. Patients who met the primary outcome had significantly lower median SDNN (13.8 [7.8, 29.1]) compared to those who did not (24.6 [15.3, 84.4]; p = 0.004). A median SDNN of 20 ms resulted in a sensitivity of 68% and specificity of 69%. Median SDNN < 20 ms represented decreased freedom from primary outcome (p = 0.043) and a hazard ratio of 2.2 in multivariate analysis (p = 0.016). Pediatric patients with ADHF who died, underwent heart transplant, or required MCS had significantly decreased HRV at presentation compared to those that did not. This supports HRV as a noninvasive tool to improve prognostication in children in ADHF.
心率变异性(HRV)是自主神经系统神经心脏相互作用健康状况的一种非侵入性指标。在成年人中,HRV降低与心血管死亡率增加相关。然而,HRV与急性失代偿性心力衰竭(ADHF)患儿预后之间的关系尚未得到描述。纳入了2013年至2019年因ADHF住院的21岁以下患者(N = 79)。主要结局定义为死亡、心脏移植或机械循环支持(MCS)。根据入院后首个24小时内获得的遥测数据计算5分钟间隔内R-R间期的中位数标准差(SDNN)。达到主要结局的患者的中位数SDNN(13.8 [7.8, 29.1])显著低于未达到主要结局的患者(24.6 [15.3, 84.4];p = 0.004)。SDNN中位数为20毫秒时,敏感性为68%,特异性为69%。SDNN中位数<20毫秒表示主要结局的自由度降低(p = 0.043),多变量分析中的风险比为2.2(p = 0.016)。与未死亡、未接受心脏移植或未需要MCS的ADHF患儿相比,死亡、接受心脏移植或需要MCS的ADHF患儿在就诊时的HRV显著降低。这支持将HRV作为一种非侵入性工具来改善ADHF患儿的预后评估。